You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
华检医疗(01931.HK)中期归母净利润增长878.8%至1.02亿元
格隆汇 08-19 23:02

格隆汇8月19日丨华检医疗(01931.HK)发布中期业绩,截至2019年6月30日止6个月,公司收益9.13亿元人民币(下同),同比增长434.1%;毛利2.15亿元,同比增长369.7%;母公司拥有人应占溢利1.02亿元,同比增长878.8%;母公司拥有人应占经调整溢利1.05亿元,同比增长147.1%;基本每股收益4.40元;不派中期股息。

公告表示,报告期内,集团保持其快速增长,成功实现收入9.13亿元,较2018年同期大幅增长434.1%。大幅增长主要是由于2019年1月完成收购威士达医疗有限公司的60%股权后,威士达连同其附属公司的财务业绩合并;及集团分销业务的自然增长。

此外,集团的净利润亦较2018年同期大幅增长897.3%。有关大幅增长主要是由于收购事项完成后,威士达连同其附属公司的财务业绩合并;及重新计量先前持有的与收购事项有关的威士达权益收益约2.64亿元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account